EG626740 Inhibitors
Scgb2b30, a member of the secretoglobin family, demonstrates a multifaceted role in cellular processes, contributing to the intricate landscape of protein homodimerization, responses to lipopolysaccharide, defense against other organisms, and positive regulation of membrane permeability. Predicted to be located in intracellular membrane-bounded organelles and the midbody, Scgb2b30's functions suggest a versatile engagement in cellular homeostasis, signaling, and response to environmental stimuli. Its potential involvement in diverse activities, ranging from cellular defense mechanisms to regulatory processes, emphasizes the significance of understanding the mechanisms underlying its expression and function. In the context of inhibition, while direct inhibitors specific to Scgb2b30 remain elusive, targeting key signaling pathways associated with its predicted functions emerges as a plausible strategy. The intricate interplay between Scgb2b30 and signaling cascades like the PI3K/Akt, MAPK, NF-κB, mTOR, JNK, and TGF-β pathways suggests a complex regulatory network. Modulating these pathways may indirectly influence Scgb2b30, potentially altering its expression or function in response to specific stimuli or cellular contexts.
The lack of specific inhibitors highlights the need for a nuanced approach, considering the diversity of Scgb2b30's activities. The predicted involvement in inflammation, as indicated by its association with NF-κB, further underscores the potential impact of targeting signaling pathways linked to immune responses. Understanding the interconnectedness of these pathways and their crosstalk may provide insights into the intricate regulatory mechanisms governing Scgb2b30 and shed light on its contributions to cellular physiology. In summary, Scgb2b30 represents a dynamic player in cellular processes, engaging in protein homodimerization, immune responses, and membrane regulation. While direct inhibitors are currently unidentified, indirect inhibition through the modulation of key signaling pathways offers a promising avenue for investigation. The predicted involvement of Scgb2b30 in diverse cellular functions underscores the need for a comprehensive exploration of its regulatory network.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
EGFR tyrosine kinase inhibitor affecting the ERK/MAPK pathway. Erlotinib's interference with the EGFR pathway may indirectly impact Scgb2b30, as EGFR signaling plays a role in cellular processes such as proliferation and differentiation, potentially influencing Scgb2b30 expression or function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor disrupting the PI3K/Akt pathway. As the PI3K/Akt pathway is implicated in cellular survival and growth, LY294002's impact may indirectly influence Scgb2b30, potentially altering its expression or function by disrupting the signaling cascades associated with this pathway. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
NF-κB inhibitor preventing its nuclear translocation. As Scgb2b30 has been associated with inflammation, BAY 11-7082's inhibition of NF-κB may indirectly affect Scgb2b30 expression or activity, potentially modulating its involvement in inflammatory responses or related processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK1 inhibitor affecting the MAPK pathway. Given Scgb2b30's potential role in cell proliferation and differentiation, PD98059's modulation of the MAPK pathway may indirectly impact Scgb2b30, influencing its expression or function by altering the signaling events within this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor suppressing mTORC1. As mTOR signaling plays a role in cellular processes, including protein synthesis and cell growth, Rapamycin's inhibition may indirectly influence Scgb2b30, potentially altering its expression or function by disrupting the mTOR pathway and its downstream effects. | ||||||
PD 169316 | 152121-53-4 | sc-204168 sc-204168A sc-204168B sc-204168C | 1 mg 5 mg 10 mg 25 mg | $88.00 $156.00 $281.00 $461.00 | 3 | |
p38 MAPK inhibitor affecting MAPK signaling. Considering the potential involvement of Scgb2b30 in inflammatory responses, SB203580's modulation of the p38 MAPK pathway may indirectly influence Scgb2b30 expression or activity, impacting its role in cellular processes associated with inflammation. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
c-Raf inhibitor targeting the Raf/MEK/ERK pathway. Given Scgb2b30's potential role in cell proliferation and differentiation, GW5074's inhibition of c-Raf may indirectly affect Scgb2b30, influencing its expression or function by disrupting the signaling events within the Raf/MEK/ERK pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor disrupting intracellular signaling. As Scgb2b30 may be associated with cellular responses, Wortmannin's impact on the PI3K pathway may indirectly influence Scgb2b30 expression or function, potentially altering its involvement in cellular processes linked to signaling cascades initiated by PI3K. | ||||||
IKK-2 Inhibitor IV | 507475-17-4 | sc-203083 | 500 µg | $133.00 | 12 | |
IKK-2 inhibitor affecting the NF-κB pathway. Considering the potential role of Scgb2b30 in inflammation, TPCA-1's inhibition of IKK-2 may indirectly influence Scgb2b30 expression or activity, potentially modulating its involvement in inflammatory responses or related processes by disrupting NF-κB signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor affecting the JNK pathway. As Scgb2b30's potential functions are diverse, including responses to lipopolysaccharide, SP600125's modulation of the JNK pathway may indirectly influence Scgb2b30, impacting its expression or activity in cellular responses to specific stimuli, such as microbial components. | ||||||